Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMA SAIFY : revenue, balance sheet and financial ratios

PHARMA SAIFY is a French company founded 11 years ago, specialized in the sector Supports juridiques de gestion de patrimoine mobilier. Based in DRANCY (93700), this company of category PME shows in 2024 a net income positive of 123 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMA SAIFY (SIREN 809464753)
Indicator 2024 2023 2022 2021 2020 2016
Revenue N/C N/C N/C N/C N/C N/C
Net income 122 763 € -112 127 € 72 698 € 93 280 € 175 578 € 76 661 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMA SAIFY generates positive net income of 123 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 77 k€ -> 123 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

122 763 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

76.98%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

69.1%

Solvency indicators evolution
PHARMA SAIFY

Sector positioning

Debt ratio
0.0 2024
2022
2023
2024
Q1: 0.0
Med: 2.75
Q3: 41.16
Excellent

In 2024, the debt ratio of PHARMA SAIFY (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
76.98% 2024
2022
2023
2024
Q1: 7.81%
Med: 60.44%
Q3: 91.96%
Good -8 pts over 3 years

In 2024, the financial autonomy of PHARMA SAIFY (77.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 407.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

407.587

Liquidity indicators evolution
PHARMA SAIFY

Sector positioning

Liquidity ratio
407.59 2024
2022
2023
2024
Q1: 142.73
Med: 746.83
Q3: 3595.15
Average -16 pts over 3 years

In 2024, the liquidity ratio of PHARMA SAIFY (407.59) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of PHARMA SAIFY in its sector

Comparison with sector Supports juridiques de gestion de patrimoine mobilier

Valuation estimate

Based on 103 transactions of similar company sales (all years), the value of PHARMA SAIFY is estimated at 410 800 € (range 150 485€ - 1 056 071€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
103 transactions
150k€ 410k€ 1056k€
410 800 € Range: 150 485€ - 1 056 071€
NAF 5 all-time

Valuation method used

Net Income Multiple
122 763 € × 3.3x = 410 800 €
Range: 150 485€ - 1 056 072€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Supports juridiques de gestion de patrimoine mobilier)

Compare PHARMA SAIFY with other companies in the same sector:

Voir toutes les statistiques du secteur Supports juridiques de gestion de patrimoine mobilier

Frequently asked questions about PHARMA SAIFY

What is the revenue of PHARMA SAIFY ?

The revenue of PHARMA SAIFY is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMA SAIFY profitable?

Yes, PHARMA SAIFY generated a net profit of 123 k€ in 2024.

Where is the headquarters of PHARMA SAIFY ?

The headquarters of PHARMA SAIFY is located in DRANCY (93700), in the department Seine-Saint-Denis.

Where to find the tax return of PHARMA SAIFY ?

The tax return of PHARMA SAIFY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMA SAIFY operate?

PHARMA SAIFY operates in the sector Supports juridiques de gestion de patrimoine mobilier (NAF code 66.19A). See the 'Sector positioning' section above to compare the company with its competitors.